Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow are damaged. This damage leads to low numbers of one or more type of blood cells. MDS is considered as a type of cancer. Myelodysplastic syndromes are a rare group of disorders in which body no longer makes enough healthy …
Continue reading “Myelodysplastic Syndrome Treatment Market to reach US$ 5,614.1 million by 203”